Sonaro Team

Dedicated to Pioneering Innovation

Karina Gasbarrino. Sonaro

Dr. Karina Gasbarrino, PhD

Co-Founder & CEO
Kashif Khan. Sonaro

Dr. Kashif Khan, MD, PhD

Co-Founder & CSO
Alex Benjamin. Sonaro

Dr. Alex Benjamin, PhD

Chief Technology Officer
Jose L. Ramirez-Garcialuna. Sonaro

Dr. Jose L. Ramirez-GarciaLuna, MD, PhD

Chief Medical Officer
Dr. Sabir Taj. Sonaro

Dr. Sabir Taj, MD, MS, RPVI

Lead Medical Imaging Advisor
Thierry Beiko. Sonaro

Thierry Beiko, BSc

AI Developer & Biomedical Engineer
Yehor Sanko. Sonaro

Yehor Sanko, A.A.S.

Full-Stack Developer

Sonaro History

Our Journey and Vision for the Future

Sonaro Incorporated

February 2023

Sonaro Incorporated officially established with a mission to revolutionize cardiovascular care through advanced diagnostic tools like Vaso3D.

International Patent Application Submitted

April 2024

Sonaro's proprietary technology, Vaso3D, is protected under an international patent application, paving the way for secure global expansion and commercialization.

Data Collection Completion

May 2024

Completion of initial data collection for Vaso3D, providing a robust dataset to validate and refine the AI algorithms used in detecting vascular diseases.

Clinical Pilot Study

July 2024

The clinical pilot study commenced, successfully assessing the effectiveness and accuracy of Vaso3D in a real-world medical environment. The study gathered valuable feedback that was used to further improve the product. Preliminary data demonstrated a 90% reduction in ultrasound scan time with Vaso3D.

FDA Submission

Q2 2025

Vaso3D is poised for FDA submission, a critical step toward bringing this innovative diagnostic tool to market. The submission includes comprehensive data from clinical trials and pilot studies.

US Product Launch

Q4 2025

The US Product Launch is a major milestone for Vaso3D, introducing advanced vascular diagnostics nationwide. After rigorous testing and approvals, Vaso3D is set to transform stroke prevention with early detection and intervention for vascular diseases.

Highlights from Our Milestones

Team Picture 6
McGill Dobson Centre for Entrepreneurship is a steadfast supporter of Sonaro
(October 2023)
Team Picture 2
The Sonaro team among 5 start-ups showcased at the McGill Dobson Centre for Entrepreneurship’s Opening Ceremony
(September 2024)
Team Picture 3
Sonaro’s innovative technology presented at the Image Guided Therapeutics Symposium hosted by INOVAIT Canada
(June 2024)
Team Picture 1
The Sonaro team at the Quebec Consortium of High-Tech Incubators’ Demo Day
(February 2024)
Team Picture 5
Sonaro team looking sharp at the Pierre Péladeau Bursaries finals, where Sonaro proudly took home second prize
(April 2023)
Team Picture 4
Sonaro’s First Full Team Retreat in Montreal
(August 2024)